BioLineRx Ltd.
(NASDAQ : BLRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 22.03%75.406.5%$147.45m
VRXValeant Pharmaceuticals International, Inc. 1.96%19.3614.1%$113.92m
CTLTCatalent, Inc. 1.66%89.642.1%$94.53m
JAZZJazz Pharmaceuticals Plc 10.98%122.612.4%$64.97m
BHCBausch Health Cos., Inc. 2.00%19.370.0%$64.85m
TNXPTonix Pharmaceuticals Holding Corp. 6.61%1.293.9%$64.18m
ARGXargenx SE 0.57%232.930.0%$46.88m
PCRXPacira Biosciences, Inc. 1.74%56.2410.3%$44.66m
ICLRICON plc 1.71%190.274.3%$42.54m
UTHRUnited Therapeutics Corp. -0.73%113.2614.1%$42.17m
ICPTIntercept Pharmaceuticals, Inc. 0.36%47.7516.8%$41.60m
PRGOPerrigo Co. Plc -5.01%52.366.8%$40.18m
GWPHGW Pharmaceuticals Plc -0.41%134.826.2%$38.01m
MYOKMyoKardia, Inc. 1.66%99.631.8%$36.65m
AMRNAmarin Corp. Plc -3.91%6.761.5%$35.89m

Company Profile

BioLineRx Ltd. is a clinical stage biopharmaceutical company focused on oncology. The company was founded in April 2003 and is headquartered in Modi'in, Israel.